Cargando…

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

ABSTRACT: Infections are common in patients with diabetes, but increasing antibiotic resistance hampers successful bacterial clearance and calls for alternative treatment strategies. Hypoxia-inducible factor 1 (HIF-1) is known to influence the innate immune defense and could therefore serve as a pos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohanty, Soumitra, Kamolvit, Witchuda, Zambrana, Silvia, Gonzales, Eduardo, Tovi, Jonas, Brismar, Kerstin, Östenson, Claes-Göran, Brauner, Annelie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724101/ https://www.ncbi.nlm.nih.gov/pubmed/34651203 http://dx.doi.org/10.1007/s00109-021-02134-7

Ejemplares similares

Diabetes downregulates the antimicrobial peptide psoriasin and increases E. coli burden in the urinary bladder
por: Mohanty, Soumitra, et al.
Publicado: (2022)

Lupinus mutabilis Edible Beans Protect against Bacterial Infection in Uroepithelial Cells
por: Kamolvit, Witchuda, et al.
Publicado: (2018)

Vitamin D strengthens the bladder epithelial barrier by inducing tight junction proteins during E. coli urinary tract infection
por: Mohanty, Soumitra, et al.
Publicado: (2020)

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens
por: White, John Kerr, et al.
Publicado: (2022)

Metformin strengthens uroepithelial immunity against E. coli infection
por: Majhi, Rakesh Kumar, et al.
Publicado: (2021)

Uropathogenic Escherichia coli Modulates Immune Responses and Its Curli Fimbriae Interact with the Antimicrobial Peptide LL-37
por: Kai-Larsen, Ylva, et al.
Publicado: (2010)

Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells
por: Muñoz, Mindy, et al.
Publicado: (2016)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
por: Mücke, Pierre-Alexander, et al.
Publicado: (2020)

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
por: Ridyard, Kylen E., et al.
Publicado: (2021)

Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
por: SZABÓ, Lilla, et al.
Publicado: (2023)

Ag@ZnO Nanoparticles Induce Antimicrobial Peptides and Promote Migration and Antibacterial Activity of Keratinocytes
por: Majhi, Rakesh Kumar, et al.
Publicado: (2021)

Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
por: Reinholz, Markus, et al.
Publicado: (2012)

Salivary concentration of the antimicrobial peptide LL-37 in patients with oral lichen planus
por: Davidopoulou, Sotiria, et al.
Publicado: (2014)

The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs
por: Kuroda, Kengo, et al.
Publicado: (2015)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
por: Babikir, Ibrahim H., et al.
Publicado: (2018)

Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
por: Khurshid, Zohaib, et al.
Publicado: (2017)

Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy
por: Findlay, Emily Gwyer, et al.
Publicado: (2019)

Oxidative stress induced in E. coli by the human antimicrobial peptide LL-37
por: Choi, Heejun, et al.
Publicado: (2017)

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
por: Pahar, Bapi, et al.
Publicado: (2020)

OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii
por: Lin, Ming-Feng, et al.
Publicado: (2015)

Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
por: Majewski, Karol, et al.
Publicado: (2018)

SP-LL-37, human antimicrobial peptide, enhances disease resistance in transgenic rice
por: Lee, In Hye, et al.
Publicado: (2017)

Evaluation of antimicrobial peptide LL-37 for treatment of Staphylococcus aureus biofilm on titanium plate
por: Wei, Jiantong, et al.
Publicado: (2021)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds
por: Duplantier, Allen J., et al.
Publicado: (2013)

Heparan Sulfate Proteoglycan–Involving Immunomodulation by Cathelicidin Antimicrobial Peptides LL-37 and PR-39
por: Kaneider, Nicole C., et al.
Publicado: (2007)

The Human Antimicrobial Peptides Dermcidin and LL-37 Show Novel Distinct Pathways in Membrane Interactions
por: Zeth, Kornelius, et al.
Publicado: (2017)

Heterogeneous absorption of antimicrobial peptide LL37 in Escherichia coli cells enhances population survivability
por: Snoussi, Mehdi, et al.
Publicado: (2018)

OmpA-Like Proteins of Porphyromonas gingivalis Mediate Resistance to the Antimicrobial Peptide LL-37
por: Horie, Toshi, et al.
Publicado: (2018)

The Human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure
por: Engelberg, Yizhaq, et al.
Publicado: (2020)

Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model
por: Nagaoka, Isao, et al.
Publicado: (2020)

Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability
por: Gunasekera, Sunithi, et al.
Publicado: (2020)

Long-Lasting Stable Expression of Human LL-37 Antimicrobial Peptide in Transgenic Barley Plants
por: Mirzaee, Malihe, et al.
Publicado: (2021)

Self-assembly of glycerol monooleate with the antimicrobial peptide LL-37: a molecular dynamics study
por: Innocenti Malini, R., et al.
Publicado: (2020)

Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37
por: Zhuo, Haiwei, et al.
Publicado: (2022)

Cord blood antimicrobial peptide LL37 levels in preterm neonates and association with preterm complications
por: Ren, Zhuxiao, et al.
Publicado: (2022)

Enhancement of the activity of the antimicrobial peptides HNP1 and LL-37 by bovine pancreatic ribonuclease A
por: Ericksen, Bryan
Publicado: (2023)

Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37
por: Krishnamoorthy, Rajavenkatesh, et al.
Publicado: (2023)

Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands
por: Morizane, Shin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8rb80a2vhtsk090p9ejgkprqsn